World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
127
Citations
83097
World Ranking
2780
National Ranking
14

Kurt Huber publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Kurt Huber sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,067 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Kurt Huber D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Kurt Huber sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 127 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Kurt Huber is affiliated with Sigmund Freud University Vienna in Austria. Their research primarily focuses on Medicine, with a significant number of publications notably in the subfields of Cardiology and Cardiovascular Medicine, Surgery, Biomedical Engineering, Emergency Medicine, and Immunology.

The main topics covered in their work include:

  • Acute Myocardial Infarction Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Coronary Interventions and Diagnostics
  • Mechanical Circulatory Support Devices
  • Cardiac Arrest and Resuscitation
  • Lipoproteins and Cardiovascular Health
  • Heart Failure Treatment and Management

Kurt Huber has contributed to a range of recent papers, including:

  • 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery, 2022, European Heart Journal
  • Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC), 2021, The Lancet
  • Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology, 2020, European Heart Journal Acute Cardiovascular Care
  • Ticagrelor With or Without Aspirin After Complex PCI, 2020, Journal of the American College of Cardiology
  • Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS, 2020, European Heart Journal

Frequent co-authors in their work include:

  • Johann Wojta
  • Konstantin A. Krychtiuk
  • Vijay Kunadian
  • Philippe Gabríel Steg
  • Roxana Mehran

Their publications are commonly found in the following venues:

  • European Heart Journal Acute Cardiovascular Care
  • European Heart Journal
  • Journal of the American College of Cardiology
  • Clinical Research in Cardiology
  • Circulation

Best Publications

  • ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation

    Stefan K. James;Dan Atar;Luigi P. Badano;Carina Blomstrom Lundqvist

  • ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment eleva...

    C. W. Hamm;J.-P. Bassand;S. Agewall;J. Bax

  • Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.

    Frans Van de Werf;Jeroen Bax;Amadeo Betriu;Carina Blomstrom-Lundqvist

  • 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).

    Steen Dalby Kristensen;Juhani Knuuti;Antti Saraste;Stefan Anker

  • ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

    Christian W. Hamm;Jean-Pierre Bassand;Stefan Agewall;Jeroen Bax

  • Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

    John W. Eikelboom;Lars Wallentin;Stuart J. Connolly;Mike Ezekowitz

  • Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

    John H. Jh Alexander;RD D Renato D. Rd Renato D Lopes;Stefan James;Rakhi Kilaru

  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

    Matthew T. Roe;Paul W. Armstrong;Keith A.A. Fox;Harvey D. White

  • PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

    Holger Thiele;Ibrahim Akin;Marcus Sandri;Georg Fuernau

  • Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction

    Paul W. Armstrong;Anthony H. Gershlick;Patrick Goldstein;Robert Wilcox

  • How to use high-sensitivity cardiac troponins in acute cardiac care

    Kristian Thygesen;Johannes Mair;Evangelos Giannitsis;Christian Mueller

  • Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries

    Petr Widimsky;William Wijns;Jean Fajadet;Mark de Belder

  • Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

    Pierluigi Tricoci;Zhen Huang;Claes Held;David J. Moliterno

  • Guidelines on myocardial revascularization.

    Philippe Kolh;William Wijns;Nicolas Danchin;Carlo Di Mario

  • Recommendations for the use of cardiac troponin measurement in acute cardiac care

    Kristian Thygesen;Johannes Mair;Hugo Katus;Mario Plebani

  • Ticagrelor with or without Aspirin in High-Risk Patients after PCI

    Roxana Mehran;Usman Baber;Samin K Sharma;David J Cohen

  • Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.

    Michelle L. O’Donoghue;Sergio Fazio;Robert P. Giugliano;Erik S.G. Stroes

  • Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction

    Gilles Montalescot;Arnoud W. van 't Hof;Frédéric Lapostolle;Johanne Silvain

  • Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.

    Investigators;John H Alexander;Richard C Becker

  • 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).

    Steen Dalby Kristensen;Juhani Knuuti;Antti Saraste;Stefan Anker

Frequent Co-Authors

Gerald Maurer
Gerald Maurer Medical University of Vienna
Uwe Zeymer
Uwe Zeymer University of Göttingen
Gilles Montalescot
Gilles Montalescot Baim Institute for Clinical Research
Gregory Y.H. Lip
Gregory Y.H. Lip University of Liverpool
Christian W. Hamm
Christian W. Hamm University of Giessen
Lars Wallentin
Lars Wallentin Uppsala University
Christopher B. Granger
Christopher B. Granger Duke University
Robert F. Storey
Robert F. Storey University of Sheffield
Freek W.A. Verheugt
Freek W.A. Verheugt University Medical Centre Mannheim
Marco Valgimigli
Marco Valgimigli University of Bern

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine or healthcare doesn’t always mean attending medical school. There are diverse online degree pathways that offer flexibility, affordability, and access to high-demand roles within the expanding health sector.

For those interested in mental health, enrolling in the fastest pmhnp program available online can quickly prepare you for a rewarding psychiatric nurse practitioner career. Alternatively, students drawn to the business side of healthcare may consider a healthcare administration degree online to gain foundational management skills.

Graduate-level candidates seeking cost-effective pathways should explore the most affordable online mha programs to advance their qualifications. If your goal is clinical leadership or advanced practice, the cheapest dnp online programs may offer an accessible route to the highest level of nursing expertise.

These flexible online degrees open more doors in healthcare fields—helping you build rewarding careers supporting patients, systems, and communities.

Best Scientists Citing Kurt Huber

Trending Scientists

Recently Published Articles